The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. - Wikidata - wikimedia - TriplyDB

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

http://www.wikidata.org/entity/Q37593100

about

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

http://www.wikidata.org/entity/Q37593100

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@en

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@nl

type

label

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@en

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@nl

prefLabel

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@en

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@nl

P1433

Q37593100-2FF60A47-B80B-4454-A126-5C6F13360B26

P1476

Q37593100-A5B744ED-AAFC-44CF-9BCE-774A8F7DC07F

P2860

Q37593100-0B78EE18-B9E4-453A-BF12-62586E2E2B18

Q37593100-1C831911-16E7-4BBF-82FD-EE206D6A1A4B

Q37593100-285D0841-46C9-4B16-9AF1-DCF98AE748CE

Q37593100-3B4D1F8E-BA7A-4FC4-A2BC-5B2B8E51CD34

Q37593100-4C30D213-0DC2-42EF-BE45-95C413464231

Q37593100-5B7448D7-2649-4F39-8700-3AEFE9FD8108

Q37593100-5EF6B24C-15A6-42BF-B8A7-4435D1D6441F

Q37593100-6098FBD5-B08E-4B3B-ABBA-8A1D87563112

Q37593100-7C2C6976-6C78-43EC-8D48-B0F34D91A243

Q37593100-845A8317-C4E6-4B17-88D8-6AABBAC0E32A

P304

Q37593100-3F598035-251B-47B2-8F43-DC3A41BD32D6

P31

Q37593100-D3D23640-009C-46CB-9357-2E56FED594FA

P356

Q37593100-864CBE04-FBB9-4438-AC0B-CDBD8D49C0A0

P433

Q37593100-0CF4D69E-33C3-4A31-9070-676B80875100

P478

Q37593100-9C7182C7-DC63-4C64-939B-EA3DB2D03050

P50

Q37593100-7EABB693-4F4F-49F5-BA9C-1AE7B1E2C20F

P577

Q37593100-53114E05-E2C6-4E44-8B5D-00955FC9A7B1

P698

Q37593100-FAEB71DE-B2FA-488F-8EED-A02C92828066

P921

Q37593100-BA4B2163-35E3-4A11-A97F-6591FF20B6D8

P356

P1433

Expert Review of Anti-infective Therapy

P1476

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

@en

P2860

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Prolonged QT interval and torsades de pointes associated with atazanavir therapy.

Protease inhibitor-based regimens for HIV therapy: safety and efficacy.

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

The role of adherence to antiretroviral therapy in the management of HIV infection.

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.

P304

801-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.09.66

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Ploenchan Chetchotisakd

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19735222

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug